可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Ridker PM,Cushman M,Stampfer MJ,et al.inflammation aspirin and the risk of cardiovascular disease in apparently healthy men[J].N Engl J Med,1997,336(14):973-924.
[2]Patel VB,Robbins MA,Tolol EJ.C-reactive protein:A“golden marker”for inflammation and coronary artery disease[J].Cleve Clin J Med,2001,52(2):109-114.
[3]Ferranti SD,Rifai N.C-reactive protein and cardiovascular disease:a review of risk prediction and interventions[J].Clin Chim Acta,2002,317(1-2):1-15.
[4]Wen ZZ,Geng DF,Luo JG,et al.Combined use of high-sensitivity C-reactive protein and apolipoprotein B/apolipoprotein A-1 ratio prior to elective coronary angiography and oral glucose tolerance tests[J].Clin Biochem,2011,44(16):1284-1291.
[5]Arroyo-Espliguero R,Avanzas P,Quiles J,et al.C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina[J].Atherosclerosis,2009,205(1):319-324.
[6]顾 敏.CRP、尿微量清蛋白与血脂联合检测对心血管疾病早期诊断的价值[J].当代医学,2013,19(28):62-63.
[7]郭继鸿.慢性冠状动脉供血不足心电图概念的质疑[J].心电学杂志,2003,22(1):21-22.
[8]Abitbol E,Monin JL,Garot J,et al.Relationship between the ischemic threshold at the onset of wall-motion abnormality on semisupine exercise echocardiography and the extent of coronary artery disease[J].J Am Soc Echocardiogr,2004,17(2):121-125.
[9]冯培哲,李 轶.70例冠心病患者载脂蛋白A1及载脂蛋白B的检测分析[J].中国药物经济学,2013,(5):326-327.
[10]Mashayekhi NR,Sadrnia S,Chehrei A,et al.The correlation between serum ApoA1 and B and Coronary Artery Disease as well as its severity[J].Int Cardiovasc Res J,2014,8(1):1-5.